ETF profile for Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
PILL ETF Profile
| Family: |
Direxion Shares |
| Name: |
Direxion Daily Pharmaceutical & Medical Bull 3X ETF |
|
|
| Inception Date: |
15-Nov-2017 |
| Termination Date: |
|
| Investment Objective: |
The Direxion Daily Pharmaceutical & Medical Bull 3X ETF seek daily investment results, before fees and expenses of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the Global Industry Classification Standard (GICS) pharmaceuticals sub-industry. To be eligible for inclusion in the Index, stocks must satisfy one of the following combined size and liquidity criteria: (1) have a float-adjusted market capitalization above $300 million with a float-adjusted liquidity ratio (defined by dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the Index rebalancing reference date) above 50%; (2) have a float-adjusted market capitalization above $500 million with a float-adjusted liquidity ratio above 90%; or (3) have a float-adjusted market capitalization above $400 million with a float-adjusted liquidity ratio above 150%. The Index is rebalanced quarterly. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| Derivatives offset |
|
-227.8188% |
| SPSIPH SWAP ASSET LEG |
|
109.9171% |
| SPSIPH SWAP ASSET LEG |
|
54.9586% |
| SPSIPH SWAP ASSET LEG |
|
53.6044% |
| GOLDMAN FINL SQ TRSRY INST 506 |
|
19.4061% |
| SPSIPH SWAP ASSET LEG |
|
9.3388% |
| DREYFUS GOVT CASH MAN INS |
|
6.0169% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT |
X9USDGLDS |
5.1698% |
| XERIS BIOPHARMA HOLDINGS INC |
XERS |
1.9650% |
| VERADERMICS INC |
MANE |
1.9267% |
|
Top 10 Holdings Weight: |
34.5% |
| Number of Holdings: |
70 |
| Shares Outstanding: |
1,050,001 |
| Total Net Assets: |
|
| NAV: |
14.78 |
| Net Expense Ratio: |
0.98% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
NYSE Intellidex proprietary model |
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Pharmaceuticals |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
Leveraged (3x) |
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
